Orbis Medicines stands at the forefront of oral macrocycle drug discovery. Our extensive pipeline is primarily directed towards developing oral macrocycle candidates targeting validated targets akin to blockbuster biologic drugs. Our objective is to introduce oral alternatives that offer significant benefits to healthcare, extending treatment options to a larger patient population. Furthermore, we are actively investigating a ...
Orbis Medicines stands at the forefront of oral macrocycle drug discovery. Our extensive pipeline is primarily directed towards developing oral macrocycle candidates targeting validated targets akin to blockbuster biologic drugs. Our objective is to introduce oral alternatives that offer significant benefits to healthcare, extending treatment options to a larger patient population. Furthermore, we are actively investigating a diverse range of therapeutic areas encompassing appealing target classes, including both intra- and extracellular targets.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.